In one paragraphArticle in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 3 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors at 4 institutions in 3 countries.
Alfredo CampennìDepartment of Biomedical and Dental Sciences and Morpho-Functional Imaging, Unit of Nuclear Medicine, University of Messina, 98125 Messina, Italy.ORCID 0000-0002-0177-939X Rosaria Maddalena RuggeriDepartment of Human Pathology DETEV, Unit of Endocrinology, University of Messina, 98122 Messina, Italy.ORCID 0000-0001-8899-684X Maria Luisa GaroDepartment of Cardiovascular Research, University Campus Biomedico, 00128 Roma, Italy.ORCID 0000-0001-6308-975X Massimiliano SiracusaDepartment of Biomedical and Dental Sciences and Morpho-Functional Imaging, Unit of Nuclear Medicine, University of Messina, 98125 Messina, Italy.
Giovanna RestucciaDepartment of Biomedical and Dental Sciences and Morpho-Functional Imaging, Unit of Nuclear Medicine, University of Messina, 98125 Messina, Italy.ORCID 0009-0000-9703-7253 Andrea RappazzoDepartment of Biomedical and Dental Sciences and Morpho-Functional Imaging, Unit of Nuclear Medicine, University of Messina, 98125 Messina, Italy.
Helena RosarnoDepartment of Biomedical and Dental Sciences and Morpho-Functional Imaging, Unit of Nuclear Medicine, University of Messina, 98125 Messina, Italy.
Antonio NicociaDepartment of Biomedical and Dental Sciences and Morpho-Functional Imaging, Unit of Nuclear Medicine, University of Messina, 98125 Messina, Italy.
Davide CardileDepartment of Biomedical and Dental Sciences and Morpho-Functional Imaging, Unit of Nuclear Medicine, University of Messina, 98125 Messina, Italy.
Petra Petranović OvčaričekDepartment of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, 10000 Zagreb, Croatia.ORCID 0000-0003-1946-2128 Sergio BaldariDepartment of Biomedical and Dental Sciences and Morpho-Functional Imaging, Unit of Nuclear Medicine, University of Messina, 98125 Messina, Italy.
Luca GiovanellaClinic for Nuclear Medicine and Competence Centre for Thyroid Diseases, Imaging Institute of Southern Switzerland, Ente Ospedaliero Cantonale, 6500 Bellinzona, Switzerland.ORCID 0000-0003-0230-0974 University of Messina · ITUniversità Campus Bio-Medico · ITUniversity of Zagreb · HRUniversity of Zurich · CH
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
objectivesTo compare the efficacy of low and moderate
methodsWe retrospectively reviewed the records of 299 low-risk DTC patients (pT1-T2, Nx(0) Mx) who had undergone (near)-total thyroidectomy followed by
resultsAn excellent response was observed in 274/299 (91.6%) patients, specifically, in 119/139 (85.6%) and 155/160 (96.9%) patients treated with low and moderate
conclusionsWhen
Indexed as
differentiated thyroid carcinomalow radioiodine activitylow-risk DTCmoderate radioiodine activityradioiodine ablationradioiodine therapy
Identifiers
PMID37173884
PMCPMC10177573
OpenAlexW4366833197
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390